Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)
Annals of Oncology, 11/04/09
Palmieri G et al. – Although the results are preliminary, CAP–GEM shows activity and safety in pretreated TETs. Furthermore, multicenter trials, also in first–line setting, are necessary to confirm the results.
Related Articles
Invasive ductal breast cancer within a malignant phyllodes tumor: case report and assessment of clonality
Human Pathology, 11/12/09
Relevance Score: 67%
Characterization of a WiT49 cell line derived orthotopic model of Wilms tumor
Pediatric Blood & Cancer, 11/03/09
Relevance Score: 67%
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma
Human Pathology, 11/12/09
Relevance Score: 66%
CCK2 receptor expression transforms non-tumorigenic human NCM356 colonic epithelial cells into tumor forming cells
International Journal of Cancer, 11/10/09
Relevance Score: 66%
Ovarian epithelial tumors of low malignant potential: a case series of 5 adolescent patients
Journal of Pediatric Surgery, 10/26/09
Relevance Score: 66%
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Malignant teratoma of the thyroid in a pregnant woman
Annals of Diagnostic Pathology, 11/23/09
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
European Journal of Endocrinology, 11/19/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
Oncogene, 11/25/09
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
Investigational New Drugs, 11/25/09
Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Clinical and Translational Oncology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


